21 projects of research of the University of Navarra have been approved in the last call of the high school Carlos III-Fondo de research Sanitaria (FIS). The academic center will receive a total of 1,767,870 euros to finance these initiatives, focused on the study of pathologies such as Parkinson's, Alzheimer's, stroke, diabetes or different types of tumors.

Of the 21 projects approved, 8 correspond to the Clínica Universidad de Navarra7 to the research center Applied Medicine (CIMA), and 6 to the Schools of Medicine, Nursing, Pharmacy and Science. Likewise, of the total money granted, 780,631 euros will go to CIMA; 610,596 to the Clinic; and 376,642 to the Schools.

Among the projects that have received the most funding are research on prognostic analysis and the identification of new therapeutic targets in non-small cell lung carcinoma; on strategies to increase surgical salvage in patients with liver tumors; and on the effect of a low-calorie Mediterranean per diem expenses and the promotion of physical activity in primary cardiovascular prevention.

Also outstanding are programs of study focused on the development of new hepatoprotective molecules; on the development and characterization of a new insulin; and on the creation of a new strategy for the prevention and treatment of a subject of ictus. The projects are funded with amounts ranging from 233,227 euros to 10,012 euros.

Upon learning of the results, Professor Iciar Astiasarán, Vice President of research of the University of Navarra, expressed her satisfaction with the approved projects, which represent "a reinforcement of the University of Navarra's commitment to biomedical research , as a way of contributing its scientific resources to research that can be returned to society". He also emphasized that these projects "will bring to Navarra almost two million euros for research biomedical, especially at a time when, as we know, it is very difficult to obtain funds for research".